Enzyme immunoassay for the quantitative determination of Ustekinumab (Stelara®) in serum and plasma.

This kit has been especially developed for the quantitative determination of ustekinumab in serum and plasma samples between the Cmin and Cmax range of concentrations.

Ustekinumab Drug Bank Accession Number is DB05679.

Ustekinumab is a targeted antibody therapy used to manage inflammatory conditions such as plaque psoriasis, psoriatic arthritis, Crohn"s Disease, and ulcerative colitis.

DB05679Ustekinumab is a human immunoglobulin (Ig) G1 kappa monoclonal antibody directed against interleukin(IL)-12 and IL-23, which are cytokines that are involved in immune and inflammatory responses.

All SHIKARI® ELISA kits are suitable for biosimilar work.

All SHIKARI® ELISA kits are produced under ISO 13485 quality system and have CE IVD mark.

For technical inquiry, please contact techsupport@matriksbiotek.com

Matriks Biotek® is a biotechnology company that conducts research on biotechnology, developing products and offering its products at a global scale helping people to lead a better life.